For as many as 8 out of 10 preteens and adolescent teens, acne is a side effect of puberty. In an effort to safeguard skin health, Galderma Laboratories created an open-label, single-center study to evaluate an acne regimen comprised of Epiduo (adapalene/benzoyl peroxide) Gel 0.1%/2.5% and Cetaphil facial cleanser and SPF 30 sunscreen.

Epiduo Gel uses two antibiotic-free medicines to treat acne. The regime for the teens also included Cetaphil DermaControl face wash and Cetaphil DermaControl Moisturizer SPF 30. These three items constitute the CoMMPlete Regimen. Galderma Laboratories presented data from the study at the American Academy of Dermatology annual meeting in Washington, DC.

“The combination of Epiduo Gel, plus Cetaphil DermaControl Face Wash and DermaControl Moisturizer with SPF 30 exhibited improvement,” says Edward Lain, MD, MBA, lead study author and Galderma consultant, in a media release from the company. “The data has successfully shown the benefits of a skincare regime to effectively treat acne vulgaris in young athletes.”

Participants in the study reported minimal skin irritation, good tolerability, and patient satisfaction when adhering to the regime. The teen athletes chosen for the study were picked for their exposure to skin irritants such a heat, moisture, friction, and foreign cells such as sweat and dirt. Obstructions in the microscopic exocrine glands can increase the likelihood of breakouts as well as irritation caused by the use of athletic equipment such as pads, helmets, and tight clothing/uniforms.

“At Galderma, we understand the impact acne has on various aspects of patients’ lives, especially among the pre-teen and teenage population,” states Miles Harrison, president and general manager of Galderma Laboratories L.P. “We are committed to science-based skin health treatment options and helping patients manage and maintain skin health through an effective skin care regimen.”

[Source(s): Galderma North America, Business Wire]